Phenobarbitone to gabapentin: a guide to 82 years of anti-epileptic drug pharmacokinetic interactions (Q40655307)

22 September 2017

1 reference

title

Phenobarbitone to gabapentin: a guide to 82 years of anti-epileptic drug pharmacokinetic interactions (English)

1 reference

22 September 2017

0 references

1 reference

P N Patsalos

1

1 reference

22 September 2017

publication date

1 September 1994

1 reference

Seizure-European Journal of Epilepsy

22 September 2017

published in

1 reference

22 September 2017

volume

3

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

163-170

1 reference

Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

The effect of concurrent administration of sodium valproate on serum levels of primidone and its metabolite phenobarbital

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Mechanism of valproate-phenobarbital interaction in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

The effects of phenytoin on phenobarbitone and primidone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Effects of Discontinuation of Phenytoin, Carbamazepine, and Valproate on Concomitant Antiepileptic Medication

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

In vitro hydroxylation of diphenylhydantoin and its inhibition by other commonly used anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Effect of sodium valproate on plasma protein binding of diphenylhydantoin

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Serum-phenytoin levels in management of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Dual effect of valproic acid on the pharmacokinetics of phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Interaction between vigabatrin and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Single-Dose Kinetics of Primidone in Human Subjects: Effect of Phenytoin on Formation and Elimination of Active Metabolites of Primidone, Phenobarbital and Phenylethylmalonamide

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Ethosuximide plasma concentrations: influence of age and associated concomitant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Valproic acid-ethosuximide interaction: a pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Side-effects induced by carbamazepine-10,11-epoxide

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11 -epoxide

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Valproic acid and diazepam interaction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Variable free and total valproic acid concentrations in sole- and multi-drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Pharmacokinetics of N-desmethylclobazam in healthy volunteers and patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

Acute effects of lamotrigine (BW430C) in persons with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2805%2980184-0

7 January 2021

10.1016/S1059-1311(05)80184-0

Identifiers

DOI

1 reference

22 September 2017

1 reference